Table 1.
Demographic, clinical and laboratory features of rheumatoid arthritis (RA) patients and healthy controls (HC)
| RA | HC | |
|---|---|---|
| n = 70 | n = 71 | |
| Age, years | 57 (18) | 58 (17) |
| Female sex, n (%) | 58 (82.9) | 57 (80) |
| HAQ (0–3) | 0.87 (1.18) | – |
| DAS‐28 | 3.24 (2.59) | – |
| CRP, mg/dl | 0.49 (0.8) | – |
| ESR, mm/h | 17 (26.5) | – |
| Steroids, n (%) | 32 (45.7) | – |
| DMARDs, n (%) | 43 (61.4) | – |
| Anti‐TNF, n (%) | 22 (31.4) | – |
| Tocilizumab, n (%) | 12 (17.1) | – |
Continuous data are expressed as median (IQR). HAQ = Health Assessment Questionnaire; DAS‐28 = Disease Activity Score‐28; CRP = C‐reactive protein; ESR = erythrocyte sedimentation rate; DMARDs = disease modifying anti‐rheumatic drugs; anti‐TNF = anti‐tumour necrosis factor.